Triclabendazole decreases intracellular cAMP. by Yong Joo Lee (357685)

K8 knockdown leads to a decrease in migration. by Nileema Khapare (159958)

Downregulation of CIP2A leads to decrease of phosphorylated Akt in lung cancer cells. by Liang Ma (37793)

Preoperative metformin administration decreased immunostaining of PP2A in endometrial cancer tissues. by Shinsuke Hanawa (4854013)

Decrease of myopia progression with 0.025% atropine by Celso Marcelo da Cunha (4894324)

“…Myopic progression was significantly lower in group 1 (-0.43 +/- 0.19 D) than in group 2 (-1.24 +/- 0.37 D) and axial length increase was also significantly smaller in group 1(0.19 +/- 0.09 mm) than in group 2 (0.48 +/- 0.12 mm). …”

Ifit2 deficiency results in decreased neuroinflammation upon RSA59 infection. by Jayasri Das Sarma (652473)

Immune response of TANs to increasing or decreasing TGF-<i>β</i>. by Yangjin Kim (191134)

“…<p>(A, B) Time courses of the N2 (<i>C</i>, red solid curve) and N1 (<i>I</i>, blue dashed curve) levels as the TGF-<i>β</i> level (<i>G</i>; black dotted line) is slowly increased (from 0 to 1.0 in (A)) and slowly decreased (from 1.0 to 0.1 in (B)), respectively. …”

Preventive administration of rapamycin permits to decrease severity of EAM. by Nicolas Prevel (483113)

Nuclear proteins increased or decreased in amount >2 fold during DENV-2 infection. by Han-Chen Chiu (542985)

Cytoplasmic proteins increased or decreased in amount >2 fold during DENV-2 infection. by Han-Chen Chiu (542985)

Oligodendrocytes in retina did not decrease after optic nerve injury. by Suqi Zou (379705)

“…(B) Cruciated scan in 3D way for counting the destiny of olig2+ cells. …”

Decrease of tumor volume by tamoxifen is not influenced by combination treatment of risperidone. by Wei-Lan Yeh (116729)

Glutamate excitotoxicity decreases GAD65/67 mRNA. by Márcio S. Baptista (365618)

Exposure to low CO₂ levels decreases ER cholesterol levels. by Nityanand Bolshette (17396845)

“…<b>(B)</b> Bioluminescence recordings from the different conditions as depicted in <b>(A)</b>, the arrow indicates the time CO₂ was shifted from 5% to 1% (mean ± SE, <i>n</i> = 4 biological replicates per condition, AUC for 0 mM 0.34 ± 0.007, 1.59 ± 0.004 (<i>P</i> < 0.0001), 0.5 mM 1.00 ± 0.023, 2.68 ± 0.04 (<i>P</i> < 0.0001), 1 mM 1.66 ± 0.07, 3.34 ± 0.04 (<i>P</i> < 0.0001), 3 mM 2.06 ± 0.02, 2.79 ± 0.07 (<i>P</i> < 0.0001), 5 mM 2.02 ± 0.05, 2.43 ± 0.06 (<i>P</i> < 0.002), 7 mM 1.85 ± 0.01, 1.77 ± 0.02 (<i>P</i> < 0.02) two-sided Student’s <i>t</i> test). …”

Activating cAMP synthesis decreases liberation of propionyl-CoA from cholesterol. by Kaley M. Wilburn (12060476)

The GluN2B-C456Y mutation decreases recombinant NMDAR currents and alters receptor properties. by Wangyong Shin (6793040)

Subjects:

Supplementary Material for: Use of the Myocardial Performance Index in Decreased Fetal Movement Assessment: A Case-Control Study by Ho D. (4108837)

“…<p><b><i>Objectives:</i></b> To determine whether there are any fetal cardiac function changes, as measured by the myocardial performance index (MPI), in pregnancies complicated by decreased fetal movement (DFM). <b><i>Methods:</i></b> We performed a prospective cross-sectional case-control study of 50 DFM and 50 uncomplicated third-trimester pregnancies matched within 2 gestational weeks. …”

WNT3 decreases GCP proliferation by inhibiting SHH dependent gene transcription. by Sandrine L. Anne (489755)

“…(<i>D</i>) WNT3 decreased Gli1, and <i>Ptch1</i> mRNA levels after 6 h of treatment (Con=1; WNT3: Gli1=0.56±0.10, Gli2=0.90±0.10, Mycn= 0.99±0.05, <i>Ptch1</i>=0.58±0.09, and <i>Ccnd1</i>=0.89±0.09). …”

Ena/VASP Mislocalization Decreases the Prevalence of Fast, Persistent-Moving Smooth Cells by Catherine I Lacayo (34086)

Ifit2 deficiency decreases CX3CR1 expression in microglia following infection. by Jayasri Das Sarma (652473)